PMID- 21843913 OWN - NLM STAT- MEDLINE DCOM- 20111108 LR - 20111117 IS - 1872-7980 (Electronic) IS - 0304-3835 (Linking) VI - 311 IP - 2 DP - 2011 Dec 8 TI - Human leukocyte antigen-G in cancer: are they clinically relevant? PG - 123-30 LID - 10.1016/j.canlet.2011.07.019 [doi] AB - The immunotolerant human leukocyte antigen (HLA)-G has direct inhibitory effects on natural killer cells (NK), dendritic cells (DC), T cells and can induce tolerant regulatory cells. The expression of HLA-G has been correlated with the tolerance of the fetus, the acceptance of organ transplants, and the immune escape of tumor cells and virus-infected cells. In the context of malignancies, aberrant induction of HLA-G expression has been extensively investigated and its clinical relevance has been postulated. We here focus on the HLA-G expression in malignancies and its relevance to tumor cell immune escaping and disease progression. CI - Copyright (c) 2011 Elsevier Ireland Ltd. All rights reserved. FAU - Yan, Wei-Hua AU - Yan WH AD - Medical Research Center, Taizhou Hospital of Zhejiang Province, Wenzhou Medical College, Linhai, Zhejiang, People's Republic of China. yanwhcom@yahoo.com LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Review DEP - 20110722 PL - Ireland TA - Cancer Lett JT - Cancer letters JID - 7600053 RN - 0 (HLA Antigens) RN - 0 (HLA-G Antigens) RN - 0 (Histocompatibility Antigens Class I) SB - IM MH - HLA Antigens/*immunology MH - HLA-G Antigens MH - Histocompatibility Antigens Class I/*immunology MH - Humans MH - Neoplasms/*immunology MH - Tumor Escape/*immunology EDAT- 2011/08/17 06:00 MHDA- 2011/11/09 06:00 CRDT- 2011/08/17 06:00 PHST- 2011/06/09 00:00 [received] PHST- 2011/07/13 00:00 [revised] PHST- 2011/07/14 00:00 [accepted] PHST- 2011/08/17 06:00 [entrez] PHST- 2011/08/17 06:00 [pubmed] PHST- 2011/11/09 06:00 [medline] AID - S0304-3835(11)00433-2 [pii] AID - 10.1016/j.canlet.2011.07.019 [doi] PST - ppublish SO - Cancer Lett. 2011 Dec 8;311(2):123-30. doi: 10.1016/j.canlet.2011.07.019. Epub 2011 Jul 22.